世界のアミノグリコシド系抗生物質市場2021-2026：ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチマイシン、その他

◆英語タイトル：Global Aminoglycosides Antibiotics Market Growth 2021-2026
◆商品コード：LPI21MY9403
◆発行会社（リサーチ会社）：LP Information
◆発行日：2021年5月（※2024年版があります。お問い合わせください）
◆ページ数：167
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医薬品
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥541,680	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥812,520	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,083,360	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「アミノグリコシド系抗生物質の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチマイシン、その他など、用途別には、病院、クリニック、ポストケア施設、政府・軍事、その他などにセグメント区分してまとめました。アミノグリコシド系抗生物質のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・アミノグリコシド系抗生物質の世界市場概要（サマリー）
・アミノグリコシド系抗生物質の企業別販売量・売上
・アミノグリコシド系抗生物質の企業別市場シェア
・アミノグリコシド系抗生物質の世界市場規模 2016年-2021年：種類別（ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチマイシン、その他）
・アミノグリコシド系抗生物質の世界市場規模 2016年-2021年：用途別（病院、クリニック、ポストケア施設、政府・軍事、その他）
・アミノグリコシド系抗生物質の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・アミノグリコシド系抗生物質のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・アミノグリコシド系抗生物質のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・アミノグリコシド系抗生物質の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・アミノグリコシド系抗生物質市場の成長要因・課題・動向
・アミノグリコシド系抗生物質の世界市場予測 2021年-2026年
・アミノグリコシド系抗生物質の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・アミノグリコシド系抗生物質のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・アミノグリコシド系抗生物質のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・アミノグリコシド系抗生物質の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・アミノグリコシド系抗生物質の世界市場予測：種類別（ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチマイシン、その他）
・アミノグリコシド系抗生物質の世界市場予測：用途別（病院、クリニック、ポストケア施設、政府・軍事、その他）
・主要企業分析

【レポートの概要】

According to this latest study, the 2020 growth of Aminoglycosides Antibiotics will have significant change from previous year. By the most conservative estimates of global Aminoglycosides Antibiotics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1034.2 million in 2019. Over the next five years the Aminoglycosides Antibiotics market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 1057.5 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Aminoglycosides Antibiotics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic
Post Care Facility
Government & Military
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aminoglycosides Antibiotics Consumption 2016-2026
2.1.2 Aminoglycosides Antibiotics Consumption CAGR by Region
2.2 Aminoglycosides Antibiotics Segment by Type
2.2.1 Neomycin
2.2.2 Tobramycin
2.2.3 Gentamicin
2.2.4 Amikacin
2.2.5 Etimicin
2.2.6 Others
2.3 Aminoglycosides Antibiotics Sales by Type
2.3.1 Global Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
2.3.2 Global Aminoglycosides Antibiotics Revenue and Market Share by Type (2016-2021)
2.3.3 Global Aminoglycosides Antibiotics Sale Price by Type (2016-2021)
2.4 Aminoglycosides Antibiotics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Post Care Facility
2.4.4 Government & Military
2.4.5 Others
2.5 Aminoglycosides Antibiotics Sales by Application
2.5.1 Global Aminoglycosides Antibiotics Sale Market Share by Application (2016-2021)
2.5.2 Global Aminoglycosides Antibiotics Revenue and Market Share by Application (2016-2021)
2.5.3 Global Aminoglycosides Antibiotics Sale Price by Application (2016-2021)

3 Global Aminoglycosides Antibiotics by Company
3.1 Global Aminoglycosides Antibiotics Sales Market Share by Company
3.1.1 Global Aminoglycosides Antibiotics Sales by Company (2019-2021)
3.1.2 Global Aminoglycosides Antibiotics Sales Market Share by Company (2019-2021)
3.2 Global Aminoglycosides Antibiotics Revenue Market Share by Company
3.2.1 Global Aminoglycosides Antibiotics Revenue by Company (2019-2021)
3.2.2 Global Aminoglycosides Antibiotics Revenue Market Share by Company (2019-2021)
3.3 Global Aminoglycosides Antibiotics Sale Price by Company
3.4 Global Manufacturers Aminoglycosides Antibiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aminoglycosides Antibiotics Product Location Distribution
3.4.2 Players Aminoglycosides Antibiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Aminoglycosides Antibiotics by Region
4.1 Global Aminoglycosides Antibiotics by Region
4.1.1 Global Aminoglycosides Antibiotics Sales by Region
4.1.2 Global Aminoglycosides Antibiotics Revenue by Region
4.2 Americas Aminoglycosides Antibiotics Sales Growth
4.3 APAC Aminoglycosides Antibiotics Sales Growth
4.4 Europe Aminoglycosides Antibiotics Sales Growth
4.5 Middle East & Africa Aminoglycosides Antibiotics Sales Growth

5 Americas
5.1 Americas Aminoglycosides Antibiotics Sales by Country
5.1.1 Americas Aminoglycosides Antibiotics Sales by Country (2016-2021)
5.1.2 Americas Aminoglycosides Antibiotics Revenue by Country (2016-2021)
5.2 Americas Aminoglycosides Antibiotics Sales by Type
5.3 Americas Aminoglycosides Antibiotics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Aminoglycosides Antibiotics Sales by Region
6.1.1 APAC Aminoglycosides Antibiotics Sales by Region (2016-2021)
6.1.2 APAC Aminoglycosides Antibiotics Revenue by Region (2016-2021)
6.2 APAC Aminoglycosides Antibiotics Sales by Type
6.3 APAC Aminoglycosides Antibiotics Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Aminoglycosides Antibiotics by Country
7.1.1 Europe Aminoglycosides Antibiotics Sales by Country (2016-2021)
7.1.2 Europe Aminoglycosides Antibiotics Revenue by Country (2016-2021)
7.2 Europe Aminoglycosides Antibiotics Sales by Type
7.3 Europe Aminoglycosides Antibiotics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Aminoglycosides Antibiotics by Country
8.1.1 Middle East & Africa Aminoglycosides Antibiotics Sales by Country (2016-2021)
8.1.2 Middle East & Africa Aminoglycosides Antibiotics Revenue by Country (2016-2021)
8.2 Middle East & Africa Aminoglycosides Antibiotics Sales by Type
8.3 Middle East & Africa Aminoglycosides Antibiotics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Aminoglycosides Antibiotics Distributors
10.3 Aminoglycosides Antibiotics Customer

11 Global Aminoglycosides Antibiotics Market Forecast
11.1 Global Aminoglycosides Antibiotics Forecast by Region
11.1.1 Global Aminoglycosides Antibiotics Forecast by Regions (2021-2026)
11.2.2 Global Aminoglycosides Antibiotics Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Aminoglycosides Antibiotics Forecast by Type
11.7 Global Aminoglycosides Antibiotics Forecast by Application

12 Key Players Analysis
12.1 Jemicare
12.1.1 Jemicare Jemicare Company Information
12.1.2 Jemicare Aminoglycosides Antibiotics Product Offered
12.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Jemicare Main Business Overview
12.1.5 Jemicare Latest Developments
12.2 Teva
12.2.1 Teva Company Information
12.2.2 Teva Aminoglycosides Antibiotics Product Offered
12.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Teva Main Business Overview
12.2.5 Teva Latest Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Aminoglycosides Antibiotics Product Offered
12.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Fangyuan-pharma
12.4.1 Fangyuan-pharma Company Information
12.4.2 Fangyuan-pharma Aminoglycosides Antibiotics Product Offered
12.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Fangyuan-pharma Main Business Overview
12.4.5 Fangyuan-pharma Latest Developments
12.5 Aike Pharmaceutical
12.5.1 Aike Pharmaceutical Company Information
12.5.2 Aike Pharmaceutical Aminoglycosides Antibiotics Product Offered
12.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Aike Pharmaceutical Main Business Overview
12.5.5 Aike Pharmaceutical Latest Developments
12.6 Cipla
12.6.1 Cipla Company Information
12.6.2 Cipla Aminoglycosides Antibiotics Product Offered
12.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Cipla Main Business Overview
12.6.5 Cipla Latest Developments
12.7 Pfizer
12.7.1 Pfizer Company Information
12.7.2 Pfizer Aminoglycosides Antibiotics Product Offered
12.7.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Pfizer Main Business Overview
12.7.5 Pfizer Latest Developments
12.8 Fresenius Kabi
12.8.1 Fresenius Kabi Company Information
12.8.2 Fresenius Kabi Aminoglycosides Antibiotics Product Offered
12.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Fresenius Kabi Main Business Overview
12.8.5 Fresenius Kabi Latest Developments
12.9 Sun Pharma
12.9.1 Sun Pharma Company Information
12.9.2 Sun Pharma Aminoglycosides Antibiotics Product Offered
12.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Sun Pharma Main Business Overview
12.9.5 Sun Pharma Latest Developments
12.10 Hikma
12.10.1 Hikma Company Information
12.10.2 Hikma Aminoglycosides Antibiotics Product Offered
12.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Hikma Main Business Overview
12.10.5 Hikma Latest Developments
12.11 Lannett Company
12.11.1 Lannett Company Company Information
12.11.2 Lannett Company Aminoglycosides Antibiotics Product Offered
12.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Lannett Company Main Business Overview
12.11.5 Lannett Company Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Aminoglycosides Antibiotics Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Neomycin
Table 3. Major Players of Tobramycin
Table 4. Major Players of Gentamicin
Table 5. Major Players of Amikacin
Table 6. Major Players of Etimicin
Table 7. Major Players of Others
Table 8. Global Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 9. Global Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 10. Global Aminoglycosides Antibiotics Revenue by Type (2016-2021) & ($ million)
Table 11. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2016-2021)
Table 12. Global Aminoglycosides Antibiotics Sale Price by Type (2016-2021)
Table 13. Global Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 14. Global Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 15. Global Aminoglycosides Antibiotics Value by Application (2016-2021)
Table 16. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2016-2021)
Table 17. Global Aminoglycosides Antibiotics Sale Price by Application (2016-2021)
Table 18. Global Aminoglycosides Antibiotics Sales by Company (2019-2021) & (M Units)
Table 19. Global Aminoglycosides Antibiotics Sales Market Share by Company (2019-2021)
Table 20. Global Aminoglycosides Antibiotics Revenue by Company (2019-2021) ($ Millions)
Table 21. Global Aminoglycosides Antibiotics Revenue Market Share by Company (2019-2021)
Table 22. Global Aminoglycosides Antibiotics Sale Price by Company (2019-2021)
Table 23. Key Manufacturers Aminoglycosides Antibiotics Producing Area Distribution and Sales Area
Table 24. Players Aminoglycosides Antibiotics Products Offered
Table 25. Aminoglycosides Antibiotics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Aminoglycosides Antibiotics Sales by Region (2016-2021) (M Units)
Table 29. Global Aminoglycosides Antibiotics Sales Market Share by Region (2016-2021)
Table 30. Global Aminoglycosides Antibiotics Revenue by Region (2016-2021) & ($ Millions)
Table 31. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2016-2021)
Table 32. Americas Aminoglycosides Antibiotics Sales by Country (2016-2021) & (M Units)
Table 33. Americas Aminoglycosides Antibiotics Sales Market Share by Country (2016-2021)
Table 34. Americas Aminoglycosides Antibiotics Revenue by Country (2016-2021) & ($ Millions)
Table 35. Americas Aminoglycosides Antibiotics Revenue Market Share by Country (2016-2021)
Table 36. Americas Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 37. Americas Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 38. Americas Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 39. Americas Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 40. APAC Aminoglycosides Antibiotics Sales by Region (2016-2021) & (M Units)
Table 41. APAC Aminoglycosides Antibiotics Sales Market Share by Region (2016-2021)
Table 42. APAC Aminoglycosides Antibiotics Revenue by Region (2016-2021) & ($ Millions)
Table 43. APAC Aminoglycosides Antibiotics Revenue Market Share by Region (2016-2021)
Table 44. APAC Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 45. APAC Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 46. APAC Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 47. APAC Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 48. Europe Aminoglycosides Antibiotics Sales by Country (2016-2021) & (M Units)
Table 49. Europe Aminoglycosides Antibiotics Sales Market Share by Country (2016-2021)
Table 50. Europe Aminoglycosides Antibiotics Revenue by Country (2016-2021) & ($ Millions)
Table 51. Europe Aminoglycosides Antibiotics Revenue Market Share by Country (2016-2021)
Table 52. Europe Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 53. Europe Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 54. Europe Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 55. Europe Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 56. Middle East & Africa Aminoglycosides Antibiotics Sales by Country (2016-2021) & (M Units)
Table 57. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Country (2016-2021)
Table 58. Middle East & Africa Aminoglycosides Antibiotics Revenue by Country (2016-2021) & ($ Millions)
Table 59. Middle East & Africa Aminoglycosides Antibiotics Revenue Market Share by Country (2016-2021)
Table 60. Middle East & Africa Aminoglycosides Antibiotics Sales by Type (2016-2021) & (M Units)
Table 61. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Type (2016-2021)
Table 62. Middle East & Africa Aminoglycosides Antibiotics Sales by Application (2016-2021) & (M Units)
Table 63. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Table 64. Global Aminoglycosides Antibiotics Sales Forecast by Type (2021-2026) & (M Units)
Table 65. Global Aminoglycosides Antibiotics Sales Market Share Forecast by Type (2021-2026)
Table 66. Global Aminoglycosides Antibiotics Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 67. Global Aminoglycosides Antibiotics Revenue Market Share Forecast by Type (2021-2026)
Table 68. Global Aminoglycosides Antibiotics Sales Forecast by Application (2021-2026) & (M Units)
Table 69. Global Aminoglycosides Antibiotics Sales Market Share Forecast by Application (2021-2026)
Table 70. Global Aminoglycosides Antibiotics Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 71. Global Aminoglycosides Antibiotics Revenue Market Share Forecast by Application (2021-2026)
Table 72. Jemicare Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 73. Jemicare Aminoglycosides Antibiotics Product Offered
Table 74. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 75. Jemicare Main Business
Table 76. Jemicare Latest Developments
Table 77. Teva Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 78. Teva Aminoglycosides Antibiotics Product Offered
Table 79. Teva Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 80. Teva Main Business
Table 81. Teva Latest Developments
Table 82. Novartis Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis Aminoglycosides Antibiotics Product Offered
Table 84. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. Fangyuan-pharma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 88. Fangyuan-pharma Aminoglycosides Antibiotics Product Offered
Table 89. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 90. Fangyuan-pharma Main Business
Table 91. Fangyuan-pharma Latest Developments
Table 92. Aike Pharmaceutical Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 93. Aike Pharmaceutical Aminoglycosides Antibiotics Product Offered
Table 94. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 95. Aike Pharmaceutical Main Business
Table 96. Aike Pharmaceutical Latest Developments
Table 97. Cipla Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 98. Cipla Aminoglycosides Antibiotics Product Offered
Table 99. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 100. Cipla Main Business
Table 101. Cipla Latest Developments
Table 102. Pfizer Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 103. Pfizer Aminoglycosides Antibiotics Product Offered
Table 104. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 105. Pfizer Main Business
Table 106. Pfizer Latest Developments
Table 107. Fresenius Kabi Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 108. Fresenius Kabi Aminoglycosides Antibiotics Product Offered
Table 109. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 110. Fresenius Kabi Main Business
Table 111. Fresenius Kabi Latest Developments
Table 112. Sun Pharma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 113. Sun Pharma Aminoglycosides Antibiotics Product Offered
Table 114. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 115. Sun Pharma Main Business
Table 116. Sun Pharma Latest Developments
Table 117. Hikma Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 118. Hikma Aminoglycosides Antibiotics Product Offered
Table 119. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 120. Hikma Main Business
Table 121. Hikma Latest Developments
Table 122. Lannett Company Basic Information, Aminoglycosides Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 123. Lannett Company Aminoglycosides Antibiotics Product Offered
Table 124. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 125. Lannett Company Main Business
Table 126. Lannett Company Latest Developments
List of Figures
Figure 1. Picture of Aminoglycosides Antibiotics
Figure 2. Aminoglycosides Antibiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aminoglycosides Antibiotics Sales Growth Rate 2016-2026 (M Units)
Figure 7. Global Aminoglycosides Antibiotics Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Aminoglycosides Antibiotics Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Neomycin
Figure 10. Product Picture of Tobramycin
Figure 11. Product Picture of Gentamicin
Figure 12. Product Picture of Amikacin
Figure 13. Product Picture of Etimicin
Figure 14. Product Picture of Others
Figure 15. Global Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 16. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2016-2021)
Figure 17. Aminoglycosides Antibiotics Consumed in Hospital
Figure 18. Global Aminoglycosides Antibiotics Market: Hospital (2016-2021) & (M Units)
Figure 19. Aminoglycosides Antibiotics Consumed in Clinic
Figure 20. Global Aminoglycosides Antibiotics Market: Clinic (2016-2021) & (M Units)
Figure 21. Aminoglycosides Antibiotics Consumed in Post Care Facility
Figure 22. Global Aminoglycosides Antibiotics Market: Post Care Facility (2016-2021) & (M Units)
Figure 23. Aminoglycosides Antibiotics Consumed in Government & Military
Figure 24. Global Aminoglycosides Antibiotics Market: Government & Military (2016-2021) & (M Units)
Figure 25. Aminoglycosides Antibiotics Consumed in Others
Figure 26. Global Aminoglycosides Antibiotics Market: Others (2016-2021) & (M Units)
Figure 27. Global Aminoglycosides Antibiotics Sales Market Share by Application (2016-2021)
Figure 28. Global Aminoglycosides Antibiotics Revenue Market Share by Application in 2020
Figure 29. Global Aminoglycosides Antibiotics Revenue Market by Company in 2020 ($ Million)
Figure 30. Global Aminoglycosides Antibiotics Revenue Market Share by Company in 2020
Figure 31. Global Aminoglycosides Antibiotics Sales Market Share by Regions (2016-2021)
Figure 32. Global Aminoglycosides Antibiotics Revenue Market Share by Region in 2020
Figure 33. Americas Aminoglycosides Antibiotics Sales 2016-2021 (M Units)
Figure 34. Americas Aminoglycosides Antibiotics Revenue 2016-2021 ($ Millions)
Figure 35. APAC Aminoglycosides Antibiotics Sales 2016-2021 (M Units)
Figure 36. APAC Aminoglycosides Antibiotics Revenue 2016-2021 ($ Millions)
Figure 37. Europe Aminoglycosides Antibiotics Sales 2016-2021 (M Units)
Figure 38. Europe Aminoglycosides Antibiotics Revenue 2016-2021 ($ Millions)
Figure 39. Middle East & Africa Aminoglycosides Antibiotics Sales 2016-2021 (M Units)
Figure 40. Middle East & Africa Aminoglycosides Antibiotics Revenue 2016-2021 ($ Millions)
Figure 41. Americas Aminoglycosides Antibiotics Sales Market Share by Country in 2020
Figure 42. Americas Aminoglycosides Antibiotics Revenue Market Share by Country in 2020
Figure 43. Americas Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 44. Americas Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 45. United States Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 46. Canada Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 47. Mexico Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 48. Brazil Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 49. APAC Aminoglycosides Antibiotics Sales Market Share by Region in 2020
Figure 50. APAC Aminoglycosides Antibiotics Revenue Market Share by Regions in 2020
Figure 51. APAC Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 52. APAC Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 53. China Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 54. Japan Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 55. Korea Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 56. Southeast Asia Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 57. India Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 58. Australia Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 59. Europe Aminoglycosides Antibiotics Sales Market Share by Country in 2020
Figure 60. Europe Aminoglycosides Antibiotics Revenue Market Share by Country in 2020
Figure 61. Europe Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 62. Europe Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 63. Germany Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 64. France Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 65. UK Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 66. Italy Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 67. Russia Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 68. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Country in 2020
Figure 69. Middle East & Africa Aminoglycosides Antibiotics Revenue Market Share by Country in 2020
Figure 70. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Type in 2020
Figure 71. Middle East & Africa Aminoglycosides Antibiotics Sales Market Share by Application in 2020
Figure 72. Egypt Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 73. South Africa Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 74. Israel Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 75. Turkey Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 76. GCC Country Aminoglycosides Antibiotics Revenue Growth 2016-2021 ($ Millions)
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のアミノグリコシド系抗生物質市場2021-2026：ネオマイシン、トブラマイシン、ゲンタマイシン、アミカシン、エチマイシン、その他(Global Aminoglycosides Antibiotics Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp